Replies to post #128296 on Avid Bioservices Inc (CDMO)

[JAKE17]

QUOTE "

" I look forward to being involved in the upcoming Phase III trial and to seeing the potential of bavituximab in other indications and combinations," said Martin J. Edelman, M.D., Professor of Medicine at the University of MarylandGreenebaum Cancer Center.